Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-15-003739
Filing Date
2015-11-16
Accepted
2015-11-16 16:04:28
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cocp10q_sep302015.htm 10-Q 703099
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER (302) ex31-1.htm EX-31.1 10957
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER (302) ex31-2.htm EX-31.2 11586
4 CERTIFICATION OF PRINCIPAL EXECUTIVE AND PRINCIPAL FINANCIAL OFFICER (906) ex32-1.htm EX-32.1 8421
  Complete submission text file 0001415889-15-003739.txt   2813554

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cocp-20150930.xml EX-101.INS 364512
6 XBRL TAXONOMY EXTENSION SCHEMA cocp-20150930.xsd EX-101.SCH 33278
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cocp-20150930_cal.xml EX-101.CAL 44817
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cocp-20150930_def.xml EX-101.DEF 107525
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cocp-20150930_lab.xml EX-101.LAB 221999
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cocp-20150930_pre.xml EX-101.PRE 187465
Mailing Address 1860 MONTREAL ROAD TUCKER GA 30084
Business Address 1860 MONTREAL ROAD TUCKER GA 30084 (425) 398-7178
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55158 | Film No.: 151234308
SIC: 2834 Pharmaceutical Preparations